Financials

  • Market Capitalization 398.74 M
  • Employee 59
  • Founded 2017
  • CEO N/A
  • Website www.lexeotx.com
  • Headquarter New York, United States
  • FIGI BBG00YB1C8M5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3069
GALT
Galectin Therapeutics Inc. - Common Stock
4.02 USD-2.90%+9.24%+23.31%-6.07%405.42 M USD
3076
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.04 USD-4.49%+0.25%+1.00%+36.03%400.55 M USD
3085
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.60 USD-1.45%+1.19%+4.78%+56.32%396.11 M USD
3090
CTNM
Contineum Therapeutics, Inc. - Common stock
17.05 USD-1.16%+0.29%+8.25%+11.66%393.84 M USD

Notizie